Analysts expect that a plan by Chinese authorities to inject capital into major state-owned insurers will ease capital constraints and solvency pressures that have prevented insurers from investing more long-term funds in the stock market. Led by China's Ministry of Finance, the capital injection totaling $54 billion will be carried out in state-owned insurers and banks, as announced by the companies involved on the 6th. This is a coordinated effort by the Chinese government to strengthen capital across the financial system. It is the first time China has used special bonds to support insurers. The capital increase will strengthen state-owned insurers, which have been directed to support the stock market with medium- and long-term funds, and may also help regulators manage smaller, riskier insurers. Gary Ng, senior economist for Asia-Pacific at Natixis, noted that "the government-led capital injection will make it easier for insurers to buy stocks and meet solvency requirements." He referred to the Chinese government's requirement since early last year that insurers invest 30% of new premiums in equities. According to him, based on the five major listed insurers in mainland China, the asset allocation ratio to equities was only 21% as of the end of 2025.
